TP53 and cancer: The elevated TGF-β levels decrease the sensitivity of cancer cells to IR, likely via the phosphorylation of H2AX, ATM, and p53 during DNA damage responses of cancer cells and via HIF-1α/vascular endothelial growth factor (VEGF) activation for angiogenesis (Farhood et al., 2020).